Abstract
This chapter explores the premise that assessment of a drug’s effect in the CNS requires consideration of not only the receptors targeted by the drug but also the cerebral regions and neuronal circuits that are functionally modulated by the drug in vivo. A series of combined drug and behavioural PET rCBF activation paradigms are described to illustrate this conjecture.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Bench CJ, Lammertsma AA, Dolan RJ, Grasby PM, Warrington SJ, Gunn K, Cuddigan M, Turton DJ, Osman S, Frackowiak RSJ. Dose dependent occupancy of central Dopamine D2 receptors by the novel neuroleptic CP-88,059-01: a study using positron emission tomography and 11C-Raclopride. Psychopharmacology 1993;112:308–314.
Farde L, Nordstrom AL, Wiesel FA et al. Positron emission tomographic analysis of central D1 and D2 receptor occupancy in patients treated with classical neuroleptics and clozapine: relation to extrapyramidal side effects. Arch Gen Psych 1992;49:538–544.
Dewey SL, Smith GS, Logan J, Brodie JD, Simkowitz P, MacGregor RR, Fowler JS, Volkow ND, Wolf AP. Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects. Proc Natl Acad Sci 1993;90:11816–20.
Dewey SL, Smith GS, Logan J, Brodie JD, Yu DW, Ferrieri RA, King PT, MacGregor RR, Martin TP, Wolf AP, Volkow ND, Fowler JS, Meller E. GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography. J Neuroscience 1992;12:3773–3780.
Dewey SL, Smith GS, Alexoff D, Ding YS, Logan J, King P, Pappas N, MacGregor RR, Brodie JD, Fowler JS, Volkow ND, Wolf AP. Studies of the interactions of dopamine with other neurotransmitters: PET and In Vivo microdialysis experiments. Neuropsychopharmacology 1995;10:81S.
Grasby PM, Friston KJ, Bench C, Frith CD, Cowen PJ, Liddle PF, Frackowiak RSJ Dolan RJ. The effect of the 5-HT1A partial agonist, buspirone, on regional cerebral blood flow in man. Psychopharmacology 1992;108:380–386.
McCulloch J.Mapping functional alterations in the CNS with [14C]-deoxyglucose. In Iversen LL, Iversen SD, Snyder SH editors. Handbook of Psychopharmacology. New York, Plenum, 1982:321–410.
Soncrant TT, Pizzolato G, Battistin L. The use of drugs as probes of cerebral function In: Battistin L, Gerstenbrand F editors. PET and NMR: New perspectives in neuroimaging and in clinical neurochemistry. Alan R Liss 1986:131–149.
Cleghom JM, Szechtman H, Garnett ES, Nahmias C, Brown GM, Kaplan RD, Szechtman B, Franco S. Apomorphine effects on brain metabolism in neuroleptic-naive schizophrenic patients. Psychiatry Research Neuroimaging 1991; 40:135–153.
Grasby PM, Friston KJ, Bench C, Frith CD, Cowen PJ, Liddle PF, Frackowiak RSJ, Dolan RJ. The effect of apomorphine on regional cerebral blood flow in normal volunteers. Psych Med 1993; 23: 606–612.
Grasby PM, Friston KJ, Bench C, Frith CD, Paulesu E, Cowen, PJ, Liddle PF, Frackowiak RSJ, Dolan RJ. The effect of the muscarinic antagonist, scopolamine, on rCBF during the performance of a memory task. Exp Brain Res 1995 (in press).
Buchsbaum MS, Potkin SG, Siegal BV, Lohr J, Katz M, Gottschalk LA, Gulasekaram B, Marshall JF, Lottenberg S, Teng CY, Abel L, Plon L, Bunney W E. Striatal metabolic rate and clinical response to neuroleptics in schizophrenia. Arch Gen Psychiatry 1992; 49: 966–974.
Friston KJ, Grasby PM, Frith CD, Bench C, Cowen PJ, Liddle PF Frackowiak RSJ, Dolan RJ. Measuring the neuromodulatory effects of drugs in man with positron emission tomography. Neurosci Letts 1992;141:106 –110.
Grasby PM, Friston KJ, Bench C, Frith CD, Paulesu E, Cowen PJ, Liddle PF, Frackowiak RSJ, Dolan RJ. The effect of apomorphine and buspirone on regional cerebral blood flow during the performance of a cognitive task - measuring neuromodulatory effects of psychotropic drugs in man. Eur J Neurosci 1992;4:1203–1212.
Goldman-Rakic PS. Circuitry of primate prefrontal cortex and regulation of behavior by representational memory. In: Plum F, Mountcastle V, editors. Handbook of physiology: the nervous system. Baltimore: Williams & Wilkins (American physiological society Bethesda) 1985:373–417.
Sawaguchi T, Matsumara M, Kubota K. Catecholaminergic effects on neuronal activity related to a delayed response task in monkey prefrontal cortex. J Neurophysiol 1990;63:1385–1400.
Sawaguchi T, Goldman-Rakic PS. D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 1991;251:947–950.
Jenkins IH, Fernandez W, Playford ED, Lees AJ, Frackowiak RSJ, Passingham RE, Brooks DJ. Impaired activation of the supplementary motor area in Parkinson’s Disease is reversed when akinesia is treated with apomorphine. Annals Neurology 1992;32:749-757.
Daniel DG, Weinberger DR, Jones DW, Zigun JR, Coppola R, Handel S, Bigelow LB, Goldberg TE, Berman KF, Kleinman JE. The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J Neurosci 1991;11:1907–1917.
Daniel DG, Berman KF, Weinberger DR. The effect of apomorphine on regional cerebral blood flow in schizophrenia. J Neuropsych 1991;1:377–384.
Friston KJ, Frith CD, Liddle PF, Frackowiak RSJ. Functional connectivity: The prinicipal component analysis of large (PET) data sets. J Cereb Blood Flow Metab 1993;13:5–14.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Grasby, P.M., Friston, K.J. (1995). Brain Activation Under Drug Treatment. In: Comar, D. (eds) PET for Drug Development and Evaluation. Developments in Nuclear Medicine, vol 26. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-0429-6_15
Download citation
DOI: https://doi.org/10.1007/978-94-011-0429-6_15
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-4191-1
Online ISBN: 978-94-011-0429-6
eBook Packages: Springer Book Archive